Protagonist Therapeutics Inc Capital Reinvestment Ratio
Protagonist Therapeutics Inc capital reinvestment ratio. Protagonist Therapeutics Inc (PTGX) has a Capital Reinvestment Ratio of 0.00x as of March 2025, meaning it reinvests 0% of its operating cash flow ($125.36 Million) in capital expenditures ($545.00K). Check Protagonist Therapeutics Inc (PTGX) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Protagonist Therapeutics Inc (2017–2024)
Capital reinvestment ratio of Protagonist Therapeutics Inc from 2017 to 2024. This chart tracks Protagonist Therapeutics Inc's Capital Reinvestment Ratio across 2 annual periods. Also explore how fast is Protagonist Therapeutics Inc growing its equity to track the company's year-over-year net asset growth rate.
Protagonist Therapeutics Inc Capital Reinvestment Ratio by Year (2017–2024)
Protagonist Therapeutics Inc capital reinvestment ratio by year from 2017 to 2024. For the full cash flow conversion analysis, see PTGX cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.01x | $184.15 Million | $1.35 Million | ▼ -95.7% |
| 2017 | 0.17x | $3.87 Million | $666.00K | — |